Get screened
Early‑stagetype 1 diabetes can be detected before symptoms appear. Below you can findscreening initiatives in your country or internationally.
European Initiatives
EDENT1FI
European action for the Diagnosis of Early Non-clinical Type 1diabetes For disease Interception - a multi‑country European project focused on early detection of type 1 diabetes.
INNODIA
A Europe‑wide research partnership working to better understand type 1 diabetes and accelerate the development of therapies that can prevent or delay the disease.
Fr1da
A Germany‑based screening programme led by the Institute for Diabetes Research at Helmholtz Munich, focused on identifying early‑stage type 1 diabetes in children.
The ELSA Study
A national UK study that screens children (2–15) and young adults (16–17) to detect early‑stage type 1 diabetes and support families with timely information.
The D1Ce Screen project
Italy’s national screening programme that identifies children at risk of type 1 diabetes or coeliac disease.
APDP
A national leader in diabetes care in Portugal, APDP promotes early detection of type 1 diabetes with “O Dedo Que Adivinha”, a simple finger‑prick screening for children aged 3–17.
PRÊT1D
French national project for the screening and management of presymptomatic type 1 diabetes, newly supported by the ffrd.
DiaUnion
DiaUnion is a center of excellence in research into type 1 diabetes and related autoimmune diseases in Sweden and Denmark.
Growing up without Diabetes
A FEDE‑led Spanish platform dedicated to “Crecer sin Diabetes”, offering information and resources that help families understand and support early detection of type 1 diabetes.
V1ND
V1ND is a forthcoming screening initiative in the Netherlands focused on early detection of Type 1 diabetes, with more information currently available via Diabeter.
Beyond Europe
ASK
Autoimmunity Screening for Kids is a US-based initiative offering early screening for Type 1 diabetes and other autoimmune conditions in children.
TrialNet
TrialNet is an international research network that provides screening and monitoring to identify individuals at risk of developing Type 1 diabetes.
Type 1 Screen
Type 1 Screen is a screening program that helps detect early-stage Type 1 diabetes through simple blood tests, often linked to research participation.
ADIR
ADIR is a clinical research study focused on identifying and following individuals at risk of Type 1 diabetes to better understand early disease development.